KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

Amneal Pharmaceuticals (AMRX) Receivables - Net (2017 - 2026)

Amneal Pharmaceuticals has reported Receivables - Net over the past 9 years, most recently at $1000.0 for Q4 2025.

  • For Q4 2025, Receivables - Net fell 93.75% year-over-year to $1000.0; the TTM value through Dec 2025 reached $1000.0, down 93.75%, while the annual FY2025 figure was $1000.0, 93.75% down from the prior year.
  • Receivables - Net for Q4 2025 was $1000.0 at Amneal Pharmaceuticals, down from $1.4 billion in the prior quarter.
  • Over five years, Receivables - Net peaked at $1.4 billion in Q3 2025 and troughed at $1000.0 in Q4 2023.
  • A 5-year average of $691.6 million and a median of $748.2 million in 2022 define the central range for Receivables - Net.
  • Biggest five-year swings in Receivables - Net: crashed 100.0% in 2024 and later soared 20637485.71% in 2025.
  • Year by year, Receivables - Net stood at $662.6 million in 2021, then crashed by 100.0% to $12000.0 in 2022, then plummeted by 91.67% to $1000.0 in 2023, then skyrocketed by 1500.0% to $16000.0 in 2024, then crashed by 93.75% to $1000.0 in 2025.
  • Business Quant data shows Receivables - Net for AMRX at $1000.0 in Q4 2025, $1.4 billion in Q3 2025, and $807.6 million in Q2 2025.